Open interest in SHIB futures contracts spiked 33%, suggesting increased liquidity and potential for higher volatility. Technical analysis points to potential breakout from descending channel ...

BERWYN, Penn. - Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX), a biopharmaceutical company focused on non-addictive pain management solutions, announced today that it has observed positive tolerance ...

Crufts will also shine a spotlight on the plight of some of the UK and Ireland’s most iconic breeds with a Vulnerable Breed competition, taking place in the main arena Those dogs competing ...

chart review studies can generate the evidence to support increasingly complex value demonstration, reimbursement and market launch decision-making. "Drug utilization research emerged in northern ...

Typically, a starting dose of 0.2 mg per pound of body weight is recommended. For instance, a 10-pound dog would require about 2 mg. Always begin with the lowest dose and gradually increase based on ...

in dogs. Corbus Pharmaceuticals Holdings, Inc announced today the dosing of the first subject in the single ascending dose / multiple ascending dose (SAD/MAD) portion of the Phase 1 trial of CRB ...

Ultrafine particle meter-dose inhalers (MDIs) have not demonstrated superior asthma control or improved safety over older MDIs. All of the inhaled corticosteroids demonstrate efficacy with once ...